Literature DB >> 21714065

What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?

Christophe Duvoux1, Tetsuya Kiuchi, Bernhard Pestalozzi, Ronald Busuttil, Rebecca Miksad.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21714065      PMCID： PMC3417809          DOI： 10.1002/lt.22367

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  44 in total

1.  Liver transplantation for hepatocellular carcinoma.

Authors:  H Bismuth; P E Majno; R Adam
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

2.  A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma.

Authors:  Gunnar Söderdahl; Lars Bäckman; Helena Isoniemi; Christian Cahlin; Krister Höckerstedt; Ulrika Broomé; Heikki Mäkisalo; Styrbjörn Friman; Bo-Göran Ericzon
Journal:  Transpl Int       Date:  2006-04       Impact factor: 3.782

3.  Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Philippe Compagnon; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges-Philippe Pageaux; Sébastien Dharancy; Olivier Chazouillères; Daniel Cherqui; Christophe Duvoux
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

4.  A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.

Authors:  Jing Xu; Zhong-Yang Shen; Xin-Guo Chen; Qing Zhang; Hui-Jie Bian; Ping Zhu; Hui-Yun Xu; Fei Song; Xiang-Min Yang; Li Mi; Qing-Chuan Zhao; Rong Tian; Qiang Feng; Si-He Zhang; Yu Li; Jian-Li Jiang; Ling Li; Xiao-Ling Yu; Zheng Zhang; Zhi-Nan Chen
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

5.  The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.

Authors:  J W Marsh; I Dvorchik; M Subotin; V Balan; J Rakela; E P Popechitelev; V Subbotin; A Casavilla; B I Carr; J J Fung; S Iwatsuki
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

6.  [Adjuvant chemotherapy after orthotopic liver transplantation for advanced hepatocellular carcinoma].

Authors:  Zhao-Hui Zhang; Li-Wen Ma; Shi-Bing Song; Dian-Rong Xiu; Jun-Jie Wang; Xiao-Xia Yang; Yi-Mu Jia
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2005-01

7.  Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?

Authors:  Herwig Pokorny; Michael Gnant; Susanne Rasoul-Rockenschaub; Bernd Gollackner; Birgit Steiner; Günter Steger; Rudolf Steininger; Ferdinand Mühlbacher
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

8.  Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

Authors:  G B Klintmalm
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

9.  Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study.

Authors:  D Cherqui; P Piedbois; J Y Pierga; C Duvoux; D Vavasseur; J Tran Van-Nhieu; J P LeBourgeois; M Julien; P L Fagniez; D Dhumeaux
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

Review 10.  Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.

Authors:  K M Olthoff; M H Rosove; C R Shackleton; D K Imagawa; D G Farmer; P Northcross; A L Pakrasi; P Martin; L I Goldstein; A Shaked
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969
View more
  6 in total

1.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

Review 2.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Potential Role of Adjuvant Lenvatinib in Improving Disease-Free Survival for Patients With High-Risk Hepatitis B Virus-Related Hepatocellular Carcinoma Following Liver Transplantation: A Retrospective, Case Control Study.

Authors:  Bing Han; Han Ding; Shuai Zhao; Yichi Zhang; Jian Wang; Yue Zhang; Jinyang Gu
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

4.  Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis.

Authors:  Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; Jun-Fu Zhang; Chin-Hua Chen; Jann-Yuan Wang; Rey-Heng Hu; Po-Huang Lee
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

Review 5.  Frontline therapy for advanced hepatocellular carcinoma: an update.

Authors:  Mehmet Akce; Bassel F El-Rayes; Tanios S Bekaii-Saab
Journal:  Therap Adv Gastroenterol       Date:  2022-04-11       Impact factor: 4.409

6.  Progesterone increases apoptosis and inversely decreases autophagy in human hepatoma HA22T/VGH cells treated with epirubicin.

Authors:  Wen-Tsan Chang; Hsiao-Ling Cheng; Bau-Shan Hsieh; Chien-Chih Chiu; King-Teh Lee; Kee-Lung Chang
Journal:  ScientificWorldJournal       Date:  2014-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.